3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
US5932576A · kind A · utility
66Cited by
7References
50Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 1998 |
| Grant date | Aug 3, 1999 |
| Priority date | — |
| Expiry date | May 22, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A class of pyrazole derivatives is described for use in treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula I ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.